Avion Wealth’s Amicus Therapeutics FOLD Stock Holding History

Avion Wealth’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-192	Closed	-$2K	–	1529
2026 Q1	$2K	Sell	192 -35	-15%	-$502	﹤0.01%	861
2025 Q4	$3K	Sell	227 -47	-17%	-$462	﹤0.01%	779
2025 Q3	$2K	Buy	274 +51	+23%	+$363	﹤0.01%	853
2025 Q2	$1K	Buy	223 +170	+321%	+$1.1K	﹤0.01%	969
2025 Q1	$0	Buy	+53	New	+$490	﹤0.01%	1140

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Avion Wealth's FOLD Position: Q2 2026 in Review

Avion Wealth sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 192 shares — an estimated $2K sold.

Avion Wealth first reported a position in FOLD in Q1 2025 and held it in 5 quarters. The position peaked at $3K in Q4 2025. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Avion Wealth reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Avion Wealth sold 192 Amicus Therapeutics shares in Q2 2026, an estimated $2K.
Avion Wealth first reported a position in Amicus Therapeutics in Q1 2025 and held it in 5 quarters.
Avion Wealth's Amicus Therapeutics position peaked at $3K in Q4 2025.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.